Sensus Healthcare (Sensus Healthcare) Cash, Cash Equivalents, Marketable Securities : $23.15 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Cash, Cash Equivalents, Marketable Securities?

Sensus Healthcare's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($20.05 Mil) to Sep. 2023 ($20.49 Mil) and increased from Sep. 2023 ($20.49 Mil) to Dec. 2023 ($23.15 Mil).

Sensus Healthcare's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($14.52 Mil) to Dec. 2022 ($25.52 Mil) but then declined from Dec. 2022 ($25.52 Mil) to Dec. 2023 ($23.15 Mil).

Sensus Healthcare Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Sensus Healthcare's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Cash, Cash Equivalents, Marketable Securities Chart

Sensus Healthcare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

15.49

14.91

14.52

25.52

23.15

Sensus Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															25.52	19.34	20.05	20.49	23.15

Sensus Healthcare Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Sensus Healthcare (NAS:SRTS) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Sensus Healthcare Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensus Healthcare (Sensus Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

5TX:Germany

Address

851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487

Website

https://www.sensushealthcare.com

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Executives

Joseph C Sardano	director, officer: Chief Executive Officer	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano	officer: GENERAL COUNSEL	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall	director	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla	officer: Chief Financial Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish	director	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman	officer: CHIEF TECHNOLOGY OFFICER	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487